Sonya C. Tate

Mechanistic Pharmacokinetic Modeling for the Prediction of Transporter-Mediated Disposition in Humans from Sandwich Culture Human Hepatocyte Data

Hannah M. Jones, Hugh A. Barton, Yurong Lai et al. · Drug Metabolism and Disposition · 2012 · 242 citations

Pharmacy, Pharmacokinetics, Pharmacology +16

Semi-Mechanistic Pharmacokinetic/Pharmacodynamic Modeling of the Antitumor Activity of LY2835219, a New Cyclin-Dependent Kinase 4/6 Inhibitor, in Mice Bearing Human Tumor Xenografts

Sonya C. Tate, Shufen Cai, Rose T. Ajamie et al. · Clinical Cancer Research · 2014 · 127 citations · Full text

Medicine, Oncology, Pharmacology +16

A Phase 1 Study of LY2874455, an Oral Selective pan-FGFR Inhibitor, in Patients with Advanced Cancer

Michael Michael, Yung‐Jue Bang, Young Suk Park et al. · Targeted Oncology · 2017 · 80 citations

Medicine, Oncology, Pharmacology +5

A Population Pharmacokinetic and Pharmacodynamic Analysis of Abemaciclib in a Phase I Clinical Trial in Cancer Patients

Sonya C. Tate, Amanda K. Sykes, Palaniappan Kulanthaivel et al. · Clinical Pharmacokinetics · 2017 · 69 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +17

Early change in tumour size predicts overall survival in patients with first-line metastatic breast cancer

Sonya C. Tate, Valérie André, Nathan Enas et al. · European Journal of Cancer · 2016 · 17 citations

Medicine, Cancer Biology, Oncology +16